Fig. 1.

Receipt of supportive medications in the first month following diagnosis of BM by class of medication and race: (A) pain medications, (B) medications for neurological symptoms, (C) psychotropic medications, and (D) other medications. Due to NCI data policies that mandate figures do not display results relevant to ≤10 patients, we could not show data on psychostimulants in the figure. Comparisons by racial subgroup via the chi-square test resulted in a P-value less than 0.05 for every class of medications except for cognitive aids.